gluconic acid has been researched along with Dyspnea in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Finzi, E | 1 |
| Bittel, B; Desai, MY; Il'Giovine, ZJ; Kumar, A; McWilliams, C; Mehra, R; Nissen, SE; Patel, D; Thomas, S; Wang, Q; Wolski, K | 1 |
1 trial(s) available for gluconic acid and Dyspnea
| Article | Year |
|---|---|
Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial.
Topics: Adult; Ambulatory Care; Antioxidants; Ascorbic Acid; Cough; COVID-19; COVID-19 Drug Treatment; Dietary Supplements; Dyspnea; Fatigue; Female; Fever; Gluconates; Humans; Male; Middle Aged; SARS-CoV-2; Severity of Illness Index; Standard of Care; Trace Elements; Treatment Outcome; Zinc | 2021 |
1 other study(ies) available for gluconic acid and Dyspnea
| Article | Year |
|---|---|
Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients.
Topics: Adult; Betacoronavirus; Coronavirus Infections; COVID-19; Dyspnea; Female; Gluconates; Humans; Male; Middle Aged; Oxygen; Pandemics; Pneumonia, Viral; SARS-CoV-2; Zinc Acetate | 2020 |